Sai Life Sciences IPO: The first public offering (IPO) of Sai Life Sciences Limited is scheduled to go live on december 18, 2024. The company's shares will be listed on the BSE and the NSE in a special pre-open session on wednesday, per the notice from the indian exchanges.

This implies that during wednesday transactions, Sai Life Sciences shares will be traded starting at 10:00 AM.Although the Sai Life Sciences IPO was issued at higher values, stock market experts say it garnered a respectable response from indian primary market investors. Therefore, the lucky allottees have little chance of receiving their money back. Despite all of these obstacles, they projected that Sai Life Sciences' shares will at least have a strong launch. They stated that the indian stock market's mood would hurt the company's IPO listing.Prediction of Sai Life Sciences' IPO listing price

"Small-molecule novel chemical entities are researched, developed, and manufactured by Sai Life Sciences Limited," stated Shivani Nyati, Head of Wealth at Swastika Investmart, in reference to Sai Life Sciences' initial public offering (IPO) listing. The company offers customised services to biotech companies and pharmaceutical corporations globally. The company's business development team consists of 16 highly qualified and experienced individuals, with six based in the United States, nine in the united kingdom and Europe, and one in Japan. The IPO received a reasonable level of interest, with ten times as many subscriptions. Its financial performance has been good, and its profitability has grown considerably.According to the Swastika Investmart analyst, Sai Life Sciences' IPO listing would come with a premium of about 13%.

Anticipating a successful launch for Sai Life Sciences' stock, Palak Devadiga, Research Analyst at StoxBox, stated "Sai Life Sciences Ltd. has attracted significant investor attention, with its IPO oversubscribed by 10.27 times, and is set for a strong debut on december 18, 2024, potentially commanding an 11% premium over the upper price band."Sai Life Sciences IPO GMP today

According to stock market observers,Sai Life Sciences IPO GMP(Grey Market Premium) today is ₹62, which means the grey market is expecting Sai Life Sciences IPO listing price to be around ₹611 ( ₹549 + 62). So, the grey market is signalling around 11 per cent listing gain for the lucky allottees.

Find out more: